Probiotics to Treat "Inflammatory Depression"

Exclusion Criteria

• •1. Serious or unstable medical illness that in the investigator's opinion could compromise response to treatment or interpretation of study results.
• •2. Known or suspected allergy to the study compounds.
• •3. Ongoing infection.
• •4. A diagnosis of psychotic disorder, bipolar disorder, personality disorder mental retardation, dementia, or individual whom, due to other causes, lack the ability to make an informed decision.
• •5. Ongoing ECT.
• •6. Patients who, in the investigator's judgment, pose a current, serious suicidal.
• •7. A diagnosis for any Substance Use Disorder (except nicotine or caffeine) in the 3 months prior to the screening visit.
• •8. Any medications (within 1 week of baseline or during the trial) that might confound the biomarker findings, including: Regular ingestion of NSAIDs or COX-2 inhibitors, or any use of oral steroids, immunosuppressants, interferon, chemotherapy (Patients will be instructed not to take an NSAID, COX-2 inhibitor or Aspirin in the 24 hours prior to a biomarker assessment visit).
• •9. Antibiotic treatment/consumption within four (4) weeks before baseline visit.
• •10. Patients who have taken foods or supplements with Probiotics later than two (2) weeks before baseline visit.
• •11. Active participation in other clinical studies with ongoing study visits.
• •12. Pregnancy.